Inbrija 42 mg/1 (Levodopa CAPSULE) 42 mg/1

Inbrija 42 mg/1 capsules are designed for inhalation, offering a convenient form of levodopa for respiratory administration. This medication is commonly used to manage symptoms associated with Parkinson's disease, providing targeted relief when needed.

Strength

42 mg/1

Pack Size

8 BLISTER PACK in 1 CARTON (0259-6142-32) / 4 CAPSULE in 1 BLISTER PACK (0259-6142-01)

Manufacturer / TM Owner

Merz Pharmaceuticals, LLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Inbrija 42 mg/1 capsules are primarily used for the treatment of Parkinson's disease. Levodopa, the active ingredient, is often utilized to address motor symptoms such as tremors, stiffness, and difficulty moving. This medication is specifically formulated for inhalation, allowing for quick absorption and potential relief from symptoms. Many individuals wonder, 'What is Inbrija used for?' and the answer lies in its ability to provide targeted support for those managing Parkinson's disease.

Side Effects

Inbrija 42 mg/1 capsules may cause common effects such as cough, nausea, and upper respiratory tract irritation due to its inhalation route. Some users might experience dizziness or headache. As with any medication, individual responses can vary, and it's important to monitor how your body reacts to this form of levodopa.

Precautions & Warnings

Inbrija 42 mg/1 capsules should be handled with care, ensuring proper storage and usage instructions are followed. It is important to use this medication as directed and to consult with a healthcare provider regarding any pre-existing conditions or allergies. Always follow the recommended guidelines for inhalation to minimize potential irritation.

Avoid Interactions

Inbrija 42 mg/1 capsules may interact with certain medications, including other Parkinson's disease treatments, antidepressants, and blood pressure medications. It is advisable to discuss all current medications with a healthcare provider to avoid potential interactions. Additionally, alcohol and other respiratory irritants should be avoided while using this medication.

Frequently Asked Questions

Inbrija is used to manage symptoms of Parkinson's disease, such as tremors and stiffness, through inhalation.

Inbrija capsules are designed for inhalation using a specific inhaler device.

Common side effects may include cough, nausea, and upper respiratory tract irritation.

Inbrija may interact with other medications, so it's important to consult a healthcare provider before combining treatments.

Inbrija is formulated for specific use cases, and suitability should be determined by a healthcare provider.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.